New blood test predicts multiple sclerosis risk years before symptoms appear

A research team at the Medical University of Vienna has developed a blood test that allows the identification of individuals at risk for developing multiple sclerosis (MS) with a high degree of certainty years before the onset of symptoms. As a result, in the future, diagnostic and therapeutic measures could be taken early enough to delay or even prevent the onset of the disease. The research has just been published in Nature Communications.
Read More

Hidden danger: Study maps rise of cardiovascular-kidney-metabolic syndrome in the US

One in three adults in the U.S. has three or more risk factors for a newly recognized but increasingly common condition: cardiovascular-kidney-metabolic (CKM) syndrome. First recognized by the American Heart Association (AHA) in a 2023 presidential advisory, CKM connects heart and metabolic health with kidney function as intertwined drivers of cardiovascular disease (CVD).
Read More

Hepatitis C treatment is not reaching some at-risk populations

As the opioid epidemic has worsened in the United States, prevalence of hepatitis C has also increased. Hepatitis C is a bloodborne virus that damages the liver. It is mainly spread through sharing needles or other injection equipment and can also be passed from a mother to baby during pregnancy or childbirth. It can be safely and effectively treated by direct-acting antiviral therapies that are approved for both adults and children.
Read More

From COVID to cancer, new at-home test spots disease with startling accuracy

Got a sore throat and the sniffles? The recent rise of rapid at-home tests has made it easier to find out if you have a serious illness like COVID-19 or just a touch of spring allergies. But while quick and convenient, these at-home tests are less sensitive than those available at the doctor’s office, meaning that you may still test negative even if you are infected.
Read More
Top